These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855 [TBL] [Abstract][Full Text] [Related]
4. Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Kwan AL; Lin CL; Yanamoto H; Howng SL; Kassell NF; Lee KS Neurosurgery; 1998 Feb; 42(2):347-50; discussion 350-1. PubMed ID: 9482186 [TBL] [Abstract][Full Text] [Related]
5. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124 [TBL] [Abstract][Full Text] [Related]
6. Effect of intracisternal and intravenous calcitonin gene-related peptide on experimental cerebral vasospasm in rabbits. Toshima M; Kassell NF; Tanaka Y; Dougherty DA Acta Neurochir (Wien); 1992; 119(1-4):134-8. PubMed ID: 1481740 [TBL] [Abstract][Full Text] [Related]
7. Punica granatum L. Juice Attenuates Experimental Cerebral Vasospasm in the Rabbit Subarachnoid Hemorrhage Model: A Basilar Artery Morphometric Study and Apoptosis. Guvenc Y; Demirci A; Billur D; Aydin S; Ozeren E; Bayram P; Dilli A; Gokce EC; Yaman O; Celik H; Karatay M; Alagoz F; Kaptanoglu E J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):124-131. PubMed ID: 27509316 [No Abstract] [Full Text] [Related]
8. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Arthur AS; Fergus AH; Lanzino G; Mathys J; Kassell NF; Lee KS Neurosurgery; 1997 Dec; 41(6):1385-91; discussion 1391-2. PubMed ID: 9402590 [TBL] [Abstract][Full Text] [Related]
9. Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats. Jośko J; Hendryk S; Jedrzejowska-Szypułka H; Słowiński J; Gwóźdź B; Lange D; Harabin-Słowińska M J Physiol Pharmacol; 2000 Jun; 51(2):241-9. PubMed ID: 10898097 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Haley EC; Kassell NF; Torner JC J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326 [TBL] [Abstract][Full Text] [Related]
12. Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. Flamm ES; Adams HP; Beck DW; Pinto RS; Marler JR; Walker MD; Godersky JC; Loftus CM; Biller J; Boarini DJ J Neurosurg; 1988 Mar; 68(3):393-400. PubMed ID: 3343611 [TBL] [Abstract][Full Text] [Related]
13. Effects of the Ca++-permeable nonselective cation channel blocker LOE 908 on subarachnoid hemorrhage-induced vasospasm in the basilar artery in rabbits. Kawanabe Y; Masaki T; Hashimoto N J Neurosurg; 2003 Mar; 98(3):561-4. PubMed ID: 12650428 [TBL] [Abstract][Full Text] [Related]
14. Increased influence of calcium and nicardipine on rabbit basilar artery reactivity after brief subarachnoid hemorrhage. Debdi M; Seylaz J; Sercombe R J Cardiovasc Pharmacol; 1993 May; 21(5):754-9. PubMed ID: 7685445 [TBL] [Abstract][Full Text] [Related]
15. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Shibuya M; Suzuki Y; Enomoto H; Okada T; Ogura K; Sugita K Acta Neurochir (Wien); 1994; 131(1-2):19-25. PubMed ID: 7709781 [TBL] [Abstract][Full Text] [Related]
16. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677 [TBL] [Abstract][Full Text] [Related]
17. Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits. Zuccarello M; Lewis AI; Upputuri S; Farmer JB; Anderson DK J Neurotrauma; 1994 Dec; 11(6):691-8. PubMed ID: 7723068 [TBL] [Abstract][Full Text] [Related]
18. Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage. Kwan AL; Lin CL; Yen CP; Winardi W; Su YF; Winardi D; Dai ZK; Jeng AY; Kassell NF; Howng SL; Wang CJ Exp Biol Med (Maywood); 2006 Jun; 231(6):1069-74. PubMed ID: 16741051 [TBL] [Abstract][Full Text] [Related]
19. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Zuccarello M; Boccaletti R; Romano A; Rapoport RM Stroke; 1998 Sep; 29(9):1924-9. PubMed ID: 9731620 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. Haley EC; Kassell NF; Torner JC J Neurosurg; 1993 Apr; 78(4):548-53. PubMed ID: 8450327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]